Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 7,013 | 7,413 | 6,810 | 9,047 | 11,290 |
| Operating Income | -7,013 | -7,413 | -6,810 | -9,047 | -11,290 |
| Other Income | -1,350 | -884 | -2,426 | -1,626 | -462 |
| Pre-tax Income | -8,363 | -8,297 | -9,236 | -10,673 | -11,752 |
| Net Income Continuous | -8,363 | -8,297 | -9,236 | -10,673 | -11,752 |
| Net Income | $-8,363 | $-8,297 | $-9,236 | $-10,673 | $-11,752 |
| EPS Basic Total Ops | -0.18 | -0.18 | -0.17 | -0.24 | -0.28 |
| EPS Basic Continuous Ops | -0.18 | -0.18 | -0.18 | -0.24 | -0.28 |
| EPS Diluted Total Ops | -0.18 | -0.18 | -0.17 | -0.24 | -0.28 |
| EPS Diluted Continuous Ops | -0.18 | -0.18 | -0.18 | -0.24 | -0.28 |
| EBITDA(a) | $-6,881 | $-7,271 | $-6,685 | $-8,901 | $-11,094 |